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a b s t r a c t
Rosai-Dorfman disease is considered to be one of the rare idiopathic disorders characterized by non-
painful lymphadenopathy.
We reported a case of Rosai Dorfman disease that was presented with an isolated temporoparietal
mass in an old Somalian patient.
It is a very rare condition that Rosai-Dorfman disease might shoe a temporoparietal area involvement
can be seen from a review of all literature. The presentation of the disease, differential diagnosis and
treatment were discussed.
© 2017 Faculty of Oral & Dental Medicine, Future University. Production and hosting by Elsevier B.V. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
1. Introduction
Rosai-Dorfman disease characterized by sinus histiocytosis with
massive Iymphadenopathy (SHML). Rosai and Dorfman first
described sinus histiocytosis with massive lymphadenopathy in
1969 [1]. The disease appears as a massive painless cervical aden-
opathy, andmainly affects the children or in young adults of African
ancestry.
Some variants of this disease may occur in extra-nodal sites,
often without any involvement of lymph nodes. 43% of cases occur
in extra-nodal disease, which may be widespread and most
frequently involves the respiratory tract, paranasal sinuses, visceral
organs, skin, bones, central nervous system, genitourinary tract and
orbits [2].
In some extra-nodal manifestations, patients can present soft
tissue swelling/masses.
This pathology is very rare and the involvement of tempor-
oparietal parotid gland area is exceptional. In most cases this
involvement presents lympho-proliferation in the soft tissues.
Approximately 10% of all cases of Rosai-Dorfman disease (RDD) are
associated with soft tissue involvement, but some may show a sole
manifestation of the disorder [2,3]. The cause of RDD is not yet
clear. Epstein-Barr virus [2] and human herpes virus have been
isolated in a few patients, but clear association can't be verified.
Autoimmune disease, immunocompromised, and neoplastic cell
disease may be a cause but this remains unclear [2].
Diagnosing Rosai-Dorfman disease is considered to be depen-
dent on its pathognomonic characteristics.
2. Case report
A 70year-old previously healthy female was seen with
complaint of painless swelling over the left temporoparietal-eye
area for the past four weeks. Rather than age related arthritis and
carpal tunnel syndrome, her systemic history was not significant.
On examination there was an erythematous undulant nodular
mass in the left temporal area [Figs. 1 and 2]. The lesion had a
smooth surface with normal surrounding skin and was not tender.
The mass appeared to be adherent to the underlying tissue.
Systemic evaluation of blood profile showed shifting from
normal values. The patient underwent incisional biopsy and the
mass was subjected to histopathological examination. EM exami-
nation with Haematoxylin and eosin stained sections showed a
mixed cellular infiltration, predominantly composed of histiocytes
that was mixed with lymphocytes including plasma cells and
polymorphous nuclear leucocytes. emperipolesis was shown
within several histiocytes, (displaying phagocytized lymphocytes).
The histiocytes were filled with pink cytoplasm and contained
lymphocytes, which is a pathognomic finding of rosai dorfman
disease [Figs. 3 and 4]. Stains for bacteria, fungus and acid-fast
bacilli were negative.
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The patient was started on systemic prednisolone (l mg/kg body
weight per day) on a tapering dose for a period of four weeks. After
six weeks of follow-up, there were notable regression of the lesion
and the patient was advised a follow-up after three months.
3. Discussion
The onset of disease is deceptive; its active phase seems to be
prolonged and its remission may be spontaneous with possibility
recurrence [3]. The factors that determine recurrences are not well
understood.
The predominant clinical manifestation of the disease is tumoral
cervical adenopathy (87.3% of cases) that, in most cases, is painless
and bilateral, affecting one or all cervical chains. The neck lymph
nodes are the most frequently involved, followed by inguinal,
axillary and mediastinal lymph nodes [4].
Lymph nodes are isolated, mobile, and small during the initial
stages but become adherent with disease progression, forming a
voluminous multinodular mass. The most common extra nodal
sites are the skin, the upper respiratory tract and bones. Head and
neck involvement - about 22% of extra nodal disease [5] include
involvement of the nasal cavity, the paranasal sinuses, the naso-
pharynx, submandibular glands, the parotid, the larynx, the tem-
poral bone, the intratemporal fossa, the pterygoid fossa, the
meninges and the orbit [6]. The skin is commonly affected; half of
these patients have another associated extra nodal site. Orbit and
ocular globe involvement have been reported, usually as a retro
arbitrary mass and proptosis [7]. although nodal involvement may
have occurred during an earlier phase. Fever occurs in up to 30% of
cases but was absent in our patient.
In 85% of cases, patients with Rosai-Dorfman disease are in good
general health without significant symptoms of the disease [8].
Our patient was complaining of soft tissue mass in the temporal
region, in addition to age related polyarthritis and radial tunnel
syndrome.
Laboratory alterations are frequent and include anaemia
(65.7%), leucocytosis (59.1%), neutrophilia (68.4%), increased ESR
(88.5%), and hyper-gamma-globulinemia (90%) [1,2], which was
similar to the laboratory results in our case.
The cause of the disease has not yet been established [9], but
two theories exist. In the first theory, SHML is caused by a specific
infectious process as Epstein Bar Virus and human Herpes viruses,
which have been isolated in some patients [11], based on the
generally infectious process seen at the onset of the disease
(localized adenopathy, fever, leucocytosis with neutrophilia,
increased erythrocyte sedimentation rate, and hyper-gamma-
globulinemia), which tends to spontaneously regress after some
time. However, no laboratory evidence points to an etiologic agent).
In the second theory, the disease is attributed to an abnormal
immunologic response, because depression of immunologic cells
can be observed.
A histopathological diagnosis was made and showed histiocytic
Fig. 1. Clinical photograph demonstrating erythematous indurated mass in the left
temporoparietal area (A side view).
Fig. 2. Clinical photograph demonstrating erythematous indurated mass in the left
temporoparietal area (face front).
Fig. 3. EM, showing chronic inflammatory cell infiltrate with lymphocytes, plasma
cells and histiocytes containing lymphocytes in their pink cytoplasm and demon-
strating emperipolesis.
Fig. 4. EM showing emperipolesis (black arrow).
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infiltration mixed with lymphocytes and other inflammatory cells.
One typical feature of this entity has been emperipolesis, which is
the presence of cells of one type within the cytoplasm of cells of
another lineage.
Rosai-Dorfman disease is an entity that is part of a group of
systemic disorders, which share numerous anatomic, histological
and pathophysiologic features. Therefore, a differential diagnosis of
RDD should be excluded from xantho-granulomatous disease. B-
cell lymphoma and benign lymphoid hyperplasia [1]. Other disor-
ders that may superficially resemble RDD include Burkitt's lym-
phoma, rhabdomyosarcoma, granulocytic sarcoma, neuroblastoma
and Langerhans cell histiocytosis.
The differential diagnosis of extra nodal SHML may be a chal-
lenge, and is based on the clinical and histological examination.
The differential diagnosis of Rosai-Dorfman is made following a
biopsy of the affected tissue. A small piece of the tissue is obtained
so that it can be viewed under a microscope by a pathologist, if the
cells in the tissue have certain specific characteristics, the diagnosis
of RDD can bemade. This procedure can be performed of the lymph
nodes. skin, bone, liver, lung, or bone marrow. RDD cells stain with
S100 protein and CD68 [3,10].
In histological examination the histiocytes in RDD, Langerhans
cell histiocytosis, and other histiocytosis express the S-100 protein,
(a neural tissue-specific protein) however; the pathophysiology of
this S-100 expression remains obscure. Although positive staining
for S-100 strongly suggests RDD, it is not absolutely required to
make the diagnosis in the presence of typical histology of RDD [7].
The disease is classically described to have an indolent, self-limiting
course however; this is not always the case.
Other differential diagnosis was made with lymphoreticular
malignancies such as lymphomas, Hodgkin's disease, malignant
histiocytosis and monocytic leukaemia, all of which have similar
histopathological features. Atypia in cytology and the aggressive
clinical course establish the diagnosis in most cases. Other histio-
cytosis, such as rhinoscleromas, Wegener's granulomatosis, may
also be included in the differential diagnosis [7].
Serology for HIV, toxoplasmosis and syphilis was done since
these conditions are not rare in our context. Extra nodal manifes-
tations in the head and neck are significantly more common in
SHML patients with immunological abnormalities [4,5].
The therapy for RDD is yet to be determined because of the
rarity of the disease and its propensity for spontaneous remission.
Excision, radiation therapy, chemotherapy and systemic steroids
have all been tried by different authors [10]. The first line of
interventional therapy to be considered is gross total excision along
with adjuvant steroids or more aggressive chemotherapy or
radiotherapy when necessary [8].
In our patient the disease was stable at six weeks however a
close follow-up is needed to watch for any increase in size of the
lesion or systemic spread.
Treatment depends upon the patient individually and is planned
after thorough testing to determine the extent of disease. Ideal
treatment, however, has not been established, and there is no
ongoing clinical trial [11].
It is believed that 70%e80% of patients recovered from symp-
toms without treatment, although they may have alternating epi-
sodes of exacerbation and remission of symptoms for a long period
of time, some patients with severe or persistent disease or cases
with risk of organ dysfunction may require treatment with surgery,
steroids, and/or chemotherapy. radiation therapy is rare to be used.
Chemotherapy may include vinblastine, 6-MP, and methotrexate.
Thalidomide or Gleevec. The ultimate goal of an overall treatment
plan is to use as little treatment as possible to keep the disease
under control and preserve quality of life [12].
This disease not usually threats life or induces organ dysfunc-
tion. [13] 5%e10% of patients show progress of the disease that may
damage tissue. However, for most patients, the disease is self-
limited, and the outcome is good [13,14].
3. Conclusion
Extra nodal manifestations of Rosai-Dorfman disease are rare
and it ranges from confined to a highly extensive form. The ideal
treatment has not yet been established, with surgical excision
showing a poor outcome. as the head is the preferred site of the
extra nodal form of the disease, then this disease should be
considered during differential diagnosis.
The disease considered to be a diagnostic challenge, especially
in extra nodal sites. With soft tissue involvement, the characteristic
features of large histiocytic cells with emperipolesis may be over-
shadowed by a fibro inflammatory component. In the presented
case it is easy to confuse this lesion with reactive nodules and
benign neoplasms since painless enlargement of the cervical lymph
nodes have followed the soft tissues lesions, because cutaneous
sinus histiocytosis may be unfamiliar to general pathologists, cases
limited to the skin may be under recognized. In the absence of
lymphadenopathy, a high index of diagnostic awareness is required
to recognize the disease, Histological and immunological confir-
mation is essential for definitive diagnosis.
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